BDBM770300 (R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imidazo[1,5-a]pyridine-8-carbonyl)piperidin-3-yl)-3-methyl-2-(2,2,2-trifluoroacetamido)butanamide::WO2024107778, Compound 109

SMILES CC(C)[C@@H](NC(=O)C(F)(F)F)C(=O)N[C@@H]1CN(C(=O)c2cccn3cncc23)CC[C@H]1c1cc(F)cc(Cl)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 770300   

TargetReplicase polyprotein 1ab(2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 7.91nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetReplicase polyprotein 1ab(2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 11nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetReplicase polyprotein 1ab [L3313F](2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 11nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetReplicase polyprotein 1ab [E3429A](2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 70nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetReplicase polyprotein 1ab [L3430F]](2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 149nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetReplicase polyprotein 1ab [L3313F,E3429A,L3430F](2019-nCoV)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataIC50: 477nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778

TargetAngiotensin-converting enzyme 2(Human)
Takeda Pharmaceutical

WIPO
LigandPNGBDBM770300((R)-N-((3S,4S)-4-(3-chloro-5-fluorophenyl)-1-(imid...)
Affinity DataEC50: >3.98E+4nMAssay Description: Compounds are 3 fold serially diluted for 10 doses and added to an assay plate (384w format) using ECHO, in duplicate wells. The test concentration ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/25/2025
Entry Details
WIPO WO2024107778